Cargando…
Cannabinoids: A New Group of Agonists of PPARs
Cannabinoids have been used medicinally and recreationally for thousands of years and their effects were proposed to occur mainly via activation of the G-protein-coupled receptor [Formula: see text] (cannabinoid receptor 1/2). Discovery of potent synthetic analogs of the natural cannabinoids as clin...
Autores principales: | Sun, Yan, Bennett, Andy |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2220031/ https://www.ncbi.nlm.nih.gov/pubmed/18288264 http://dx.doi.org/10.1155/2007/23513 |
Ejemplares similares
-
New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy
por: Jia, Zhanjun, et al.
Publicado: (2014) -
PPAR Agonists and Cardiovascular Disease in Diabetes
por: Calkin, Anna C., et al.
Publicado: (2008) -
Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?
por: Scatena, Roberto, et al.
Publicado: (2008) -
PPAR agonists for the treatment of primary biliary cholangitis: Old and new tales
por: Colapietro, Francesca, et al.
Publicado: (2023) -
Safety of PPAR Agonists
por: Home, Philip
Publicado: (2011)